CME Speakers
Asthma Case Studies
Stacey Denham, MSW, MPH
Stacey Denham, MSW, MPH
Public Health Manager
Stacey Denham, MSW, MPH, is a Public Health Manager at the Asthma and Allergy Foundation of America (AAFA), the nation’s oldest and leading asthma and allergy charity. She holds an MSW and MPH from Tulane University with a concentration in Maternal and Child Health. Stacey has worked in the asthma and allergy field for over 15 years with an emphasis in community health. She has worked both locally in her community of New Orleans and internationally with non-profit organizations. Stacy believes in the power, diversity, and resilience of each community and the leaders that reside in them to bring healthy behavior change to positive health outcomes. Currently, Stacey resides in New Orleans with her family, where they can be found bike riding, trying out new food spots, and going to festivals.
Anju Peters, MD, MS
Anju Peters, MD, MS
Professor of Medicine
Anju Peters, MD, MS, is a Professor in the Department of Medicine at Northwestern. Moreover, she is the Director of Clinical Research in the Division of Allergy-Immunology and the Medical Director of the Northwestern Medicine Clinical Research Unit. Furthermore, Dr. Peters is the Director of the Center for Clinical Research at the Northwestern University Clinical and Translational Sciences Institute. Her research focuses on the field of chronic rhinosinusitis and its associated comorbidities including allergic rhinitis, asthma and immunodeficiencies. Dr. Peters has published extensively in these areas and is currently involved in translational research and clinical trials in asthma and chronic rhinosinusitis. Currently, she practices as an allergist in the Division of Allergy-Immunology.
Theresa Guilbert, MD, MS
Theresa Guilbert, MD, MS
Professor
Theresa Guilbert, MD, MS, is a Professor at the University of Cincinnati and the Director of the Asthma Center at Cincinnati Children’s Hospital & Medical Center. Dr. Guilbert’s clinical research focuses on identifying the roles of risk factors, exposures, and environment interactions that lead to early childhood wheezing and severe asthma as well as treatment and intervention strategies to manage asthma. Her clinical research has utilized stakeholder input to develop, implement, and test technology-based interventions for children with asthma, and she has developed a telehealth clinic which serves several urban core school-based health centers. Dr. Guilbert is currently the site PI for several multi-center asthma pediatric trials.
Nasal Polyps Management
Kathleen Buchheit, MD
Kathleen Buchheit, MD
Assistant Professor of Medicine
Katie Buchheit, MD, is the assistant director of the AERD Center at the Brigham and Women’s Hospital (BWH) in Boston, Massachusetts. Her research focuses on understanding aspirin-exacerbated respiratory disease (AERD) and nasal polyposis. She is dedicated to investigating the causative mechanisms and exploring new treatments for these diseases. Dr. Buchheit is principal investigator of an NIH-funded study investigating the role of B cells and plasma cells in the pathogenesis of AERD and nasal polyps, as well as the mechanistic factors associated with nasal polyp recurrence. Clinically, she primarily focuses on the treatment of patients with chronic rhinosinusitis and AERD. During her allergy/immunology fellowship at BWH, she focused on the pathogenesis of nasal polyposis and AERD..jpg)
Stella Lee, MD
Stella Lee, MD
Director of the Brigham Sinus Center
Stella Lee, MD is a fellowship-trained rhinologist and chief of rhinology at Brigham and Women’s Hospital (BWH)/Harvard Medical School in Boston, Massachusetts. She is a clinician scientist developing novel management strategies for the care of patients with inflammatory upper airway disease and is a leader in developing therapeutics for airway inflammation. Before joining BWH, Dr. Lee was the division chief for sino-nasal disorders and allergy in the Department of Otolaryngology at the University of Pittsburgh Medical Center for ten years. Her research interests include defining inflammatory endotypes of chronic rhinosinusitis, the impact of environmental pollution on airway inflammation, and the development of basic to translational approaches to solve chronic inflammation.Noam Cohen, MD, PhD
Noam Cohen, MD, PhD
Professor of Otorhinolaryngology – Head and Neck Surgery, Director of Rhinology Research
Noam Cohen, MD, PhD is the Ralph Butler endowed professor of otorhinolaryngology – head and neck surgery and director of rhinology research at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. He is an adjunct member of the Monell Chemical Senses Center and a staff surgeon at the Philadelphia VA Medical Center. His research interests include host-microbe interactions in the upper airway, focusing on sinonasal innate defenses (airway taste receptors and mucociliary clearance), microbial biofilms, solitary chemosensory cells, and development of novel sinonasal topical antimicrobial therapies. He has authored more than 200 publications, given multiple presentations around the world, and has been principal investigator on NIH and VA grants, as well as industry-sponsored studies.
.jpg)
IBD
Raymond Cross, M.D., M.S., A.G.A.F., F.A.C.G
Raymond Cross, M.D., M.S., A.G.A.F., F.A.C.G
Professor of Medicine, Division of Gastroenterology and Hepatology
Raymond Cross, M.D., M.S., A.G.A.F., F.A.C.G. is a Professor of Medicine, Division of Gastroenterology and Hepatology, at the University of Maryland, Baltimore. Also, he is Director of the Inflammatory Bowel Disease Program at the University of Maryland School of Medicine and Director of the Digestive Health Center at the University of Maryland Medical Center. Dr. Cross has authored over 170 journal articles, reviews, and book chapters. His research interests include application of telemedicine in the care of patients with IBD, disparities, outcomes research and clinical trials. Furthermore, Dr. Cross is Co-Chair of the Clinical Research Alliance, Research & Investigator Engagement Lead for SPARC IBD, and Scientific Co-Director of the Corevitas Registry.
Florence-Damilola Odufalu, MD
Florence-Damilola Odufalu, MD
Assistant Professor of Clinical Medicine
Florence-Damilola Odufalu, MD is a passionate provider and clinical researcher in gastroenterology and inflammatory bowel diseases (IBD), including Crohn’s disease, ulcerative colitis, indeterminate colitis, and microscopic colitis. Her research and clinical interests include disparities research, women’s health, and pregnancy as each relates to IBD. Dr. Odufalu has published many ground-breaking research articles and reviews assessing IBD care in pregnancy and in ethnic minority groups and serves on the editorial board of Inflammatory Bowel Diseases Journal.
Food Allergy Series
Robert Wood, MD
Robert Wood, MD
Professor of Pediatrics
Dr. Robert Wood is Professor of Pediatrics, Chief of Pediatric Allergy, Immunology, and Rheumatology, Director of the Pediatric Clinical Research Unit, and Deputy Director of the Institute of Clinical and Translational Research at the Johns Hopkins University School of Medicine. He is recognized internationally as an expert in both food allergy and childhood asthma and has published over 300 manuscripts and book chapters, as well as four books. He has served on numerous editorial boards and other leadership positions, including President of the American Academy of Allergy, Asthma, and Immunology.
Edwin Kim, MD, MS
Edwin Kim, MD, MS
Associate Professor of Pediatrics
Edwin Kim, MD, MS is an associate professor of pediatrics at the University of North Carolina (UNC) School of Medicine and chief of the division of pediatric allergy and immunology. He is director of the UNC Food Allergy Initiative research group, which focuses on multiple aspects of food immunotherapy including safety and tolerability of immunotherapy, varying levels of clinical desensitization, and immune mechanisms involved in successful treatment. Dr. Kim is also interested in research that focuses on the development of novel therapeutics for food allergy. As director, his goal is to recruit and train the next generation of leaders in allergy and immunology through strong clinical training and productive research opportunities.
Jennifer Dantzer, MD, MHS
Jennifer Dantzer, MD, MHS
Assistant Professor of Pediatrics, Division of Allergy
Jennifer Dantzer, MD, MHS is a pediatric allergist and immunologist with a focus on food allergy treatments and patient-centered outcomes. She is an assistant professor of pediatrics at the Johns Hopkins School of Medicine in the division of allergy, immunology, and rheumatology. In 2021, Dr. Dantzer was awarded the Johns Hopkins Clinical Scholar Award and NIH/NIAID K23 award to study patient-centered outcomes of the first FDA-approved food allergy treatment. She is a co-investigator in the Consortium for Food Allergy Research and participates in numerous food allergy research projects. She has published numerous articles in leading allergy and immunology journals, including five review articles on novel treatments for food allergy, and has presented at several national conferences.
Hereditary Angioedema (HAE)
Luann Curry
Luann Curry
Interview Participant - Patient with HAE
Marc Riedl, MD, MS
Marc Riedl, MD, MS
Professor of Medicine
Marc Riedl, MD, MS is a professor of medicine and clinical director of the United States Hereditary Angioedema Association (US HAEA) Angioedema Center at the University of California, San Diego (UCSD), where he also serves as clinical service chief for allergy and immunology. He directs an active clinical research program focused on angioedema and immunodeficiency conditions and lectures frequently at national and international medical conferences. He has published more than 140 peer-reviewed manuscripts and serves on numerous scientific committees, as well as appointed expert panels for the US Food and Drug Administration (FDA) and National Institutes of Health (NIH). He serves on the US HAEA Medical Advisory Board, the Immune Deficiency Foundation Physician Advisory Committee, and the Board of Directors for the Western Society of Allergy, Asthma, and Immunology.
Timothy Craig, DO, FAAAAI, FACAAI, FACP, FACOI
Timothy Craig, DO, FAAAAI, FACAAI, FACP, FACOI
Tenured Professor of Medicine
Timothy Craig, DO, FAAAAI, FACAAI, FACP, FACOI is a tenured professor of medicine, pediatrics, and biomedical sciences and is a distinguished educator at Pennsylvania State University (PSU). He is director of the Allergy, Immunology, and Respiratory Clinical Research, as well as the PSU Alpha-1 Foundation Clinical Resource Center and the International Angioedema Resource Center (ACARE). He has served as a leader in multiple organizations, including the Asthma Diagnosis and Treatment Interest Section Chair for the American Academy of Allergy, Asthma & Immunology (AAAAI). He also serves on the Medical Advisory Board for the US Hereditary Angioedema Association. A successful clinical researcher and mentor, Dr. Craig has published more than 350 manuscripts, delivered more than 500 invited lectures and 450 abstracts, and has served on numerous editorial boards.
EOE
Mirna Chehade, MD, MPH, AGAF, FAAAAI
Mirna Chehade, MD, MPH, AGAF, FAAAAI
Professor of Pediatrics and Medicine
Mirna Chehade, MD, MPH is a professor of pediatrics and medicine at the Icahn School of Medicine at Mount Sinai in New York City. She is a board-certified pediatric gastroenterologist and the founding director of the Mount Sinai Center for Eosinophilic Disorders (MSCED). The center provides cutting-edge clinical care, research, and support for patients with eosinophilic gastrointestinal diseases (EGIDs) including eosinophilic esophagitis (EoE). She is an active member in national and international organizations, and has several publications on EGIDs, including the efficacy and safety of various therapies for EGIDs, potential reasons EGIDs are missed, and long-term outcomes of EGIDs. She is a frequently invited speaker at national and international meetings, and an invited reviewer for several highly ranked gastroenterology and allergy journals.
Kathryn Peterson, MD, MSci
Kathryn Peterson, MD, MSci
Professor of Medicine
Kathy Peterson, MD is a professor of medicine at the University of Utah in Salt Lake City. She also co-directs the multidisciplinary clinic for gastrointestinal eosinophilic disorders. Her specialties lie in the diagnosis and treatment of diseases of the digestive system, including eosinophilic esophagitis, Barrett’s esophagus, and inflammatory bowel disease. Her research focuses on novel methods to diagnose, risk stratify, and treat eosinophilic esophagitis and other eosinophilic gastrointestinal diseases (EGIDs). She completed her medical degree at the University of Texas Southwestern in Dallas, followed by a residency and fellowship at the University of Utah and a master’s program in epidemiology at Harvard University in Boston, MA.
Atopic Derm Point/Counterpoint
Angela Lamb, MD
Angela Lamb, MD
Associate Professor, Vice Chair of Clinical Operations
Angela Lamb, MD is a New York City dermatologist who treats patients of all ages for acne, atopic dermatitis, skin-cancer detection, and numerous other skin disorders, including many for patients undergoing cancer treatment. Serving in several leadership roles at Mount Sinai, Dr. Lamb is director of the Westside Mount Sinai Dermatology Faculty Practice and an associate professor of dermatology. She was recently promoted to System Vice Chair of Dermatology Clinical Operations and Strategy and also serves as medical director of the Mount Sinai Doctors Patient Access Center. Dr. Lamb is intent on partnering with her patients to determine the best course of treatment and ongoing care.Anne Marie Singh, MD
Anne Marie Singh, MD
Associate Professor, Interim Division Head, Division of Allergy, Immunology and Rheumatology
Anne Marie Singh, MD is an associate professor of pediatrics; interim division chief of the Division of Allergy, Immunology and Rheumatology; and director of the Food Allergy Research and Education Clinical Research Center of Distinction at the University of Wisconsin School of Medicine and Public Health. She also has affiliate appointments in the Departments of Dermatology, Medical Microbiology and Immunology, and Food Research. Dr. Singh’s research is focused on advancing the clinical care of patients with early atopic diseases, including atopic dermatitis and food allergy, as well as mechanistic studies on the effects of environmental and microbial exposures on development of allergic diseases. She is leading the Childhood Allergy and NeOnatal Environment (CANOE) birth cohort as part of NIH’s Environmental Childhood Health Outcomes (ECHO) study.
Nasal Polyps Case Studies
Stacey Denham, MSW, MPH
Stacey Denham, MSW, MPH
Public Health Manager
Stacey Denham, MSW, MPH, is a Public Health Manager at the Asthma and Allergy Foundation of America (AAFA), the nation’s oldest and leading asthma and allergy charity. She holds an MSW and MPH from Tulane University with a concentration in Maternal and Child Health. Stacey has worked in the asthma and allergy field for over 15 years with an emphasis in community health. She has worked both locally in her community of New Orleans and internationally with non-profit organizations. Stacy believes in the power, diversity, and resilience of each community and the leaders that reside in them to bring healthy behavior change to positive health outcomes. Currently, Stacey resides in New Orleans with her family, where they can be found bike riding, trying out new food spots, and going to festivals.Stella Lee, MD
Stella Lee, MD
Director of the Brigham Sinus Center
Stella Lee, MD is a fellowship-trained rhinologist and chief of rhinology at Brigham and Women’s Hospital (BWH)/Harvard Medical School in Boston, Massachusetts. She is a clinician scientist developing novel management strategies for the care of patients with inflammatory upper airway disease and is a leader in developing therapeutics for airway inflammation. Before joining BWH, Dr. Lee was the division chief for sino-nasal disorders and allergy in the Department of Otolaryngology at the University of Pittsburgh Medical Center for ten years. Her research interests include defining inflammatory endotypes of chronic rhinosinusitis, the impact of environmental pollution on airway inflammation, and the development of basic to translational approaches to solve chronic inflammation.
Nasal Polyps Expert Interview
Eugenio De Corso, MD, PhD
Eugenio De Corso, MD, PhD
Ear, Nose, and Throat Specialist
Eugenio De Corso, MD, PhD is an ear, nose, and throat specialist at the Institute of Otorhinolaryngology, A. Gemelli University Hospital Foundation, Catholic University of the Sacred Heart in Rome, Italy. His principal areas of clinical expertise are nasal polyps, chronic rhinosinusitis, allergic and nonallergic rhinitis, sinusitis, and otitis media. His research interests include endoscopic treatment, laryngectomy, brachytherapy, otosclerosis surgery, type 2 inflammation in nonallergic rhinitis, and the management of patients with chronic rhinosinusitis with nasal polyps (CRSwNP). He has overseen clinical studies of patients undergoing new therapies, such as biologics for severe uncontrolled CRSwNP and the efficacy of biologics on refractory eosinophilic otitis media associated with CRSwNP. He has authored or co-authored more than 100 publications and has reviewed several international journals.
Marco Caminati, MD
Marco Caminati, MD
Allergy and Clinical Immunology Specialist
Marco Caminati, MD is an allergy and clinical immunology specialist, as well as an assistant professor in allergy, clinical immunology, and severe asthma at the University of Verona Asthma Center and Allergy Unit at Verona University Hospital in Verona, Italy. Most of his clinical and scientific activity focuses on asthma, severe asthma, and associated comorbidities, including chronic rhinosinusitis with nasal polyps (CRSwNP), as well as biologics and immunotherapy. His research interests include rare autoimmune disorders with hypereosinophilic syndrome (HES), eosinophilic granulomatosis with polyangiitis (EGPA), and eosinophilic esophagitis (EoE), with a special focus on new targeted therapies. He co-chaired the Junior Members Steering Group of the World Allergy Organization (WAO) and was involved in the European Academy of Allergy and Clinical Immunology (EAACI) Junior Member Assembly.
Clinical Updates in Chronic Graft vs Host Disease
.jpg)
Zachariah DeFilipp, MD
Zachariah DeFilipp, MD
Director of BMT Clinical Research
Zachariah DeFilipp, MD, is an attending physician in the Hematopoietic Cell Transplant and Cell Therapy Program at the Massachusetts General Hospital Cancer Center. He serves as Director of BMT Clinical Research and an Assistant Professor in Medicine at Harvard Medical School. Dr. DeFilipp is involved in translational and clinical research initiatives to improve outcomes for patients undergoing allogeneic hematopoietic cell transplantation. His research is on the development of approaches to the prevention and treatment of graft-versus-host disease. Also, his research efforts have explored improving transplant outcomes for high-risk leukemia through the incorporation of targeted agents in pre- and post-transplant and examining late effects following amongst long-term transplant survivors.
Andrew Rogers
Andrew Rogers
Assistant Professor of Medicine
Andrew Rogers, MD is a hematologist at MaineHealth Cancer Care in South Portland, Maine. He serves as assistant program director for the Hematology/Medical Oncology Fellowship program at Maine Medical Center. He completed his fellowship training in hematology and medical oncology at The Ohio State University in Columbus, Ohio. His clinical interests include blood cancers such as leukemia, lymphoma, and myeloma.
.jpg)
Food Allergy
Edwin Kim, MD, MS
Edwin Kim, MD, MS
Associate Professor of Pediatrics
Edwin Kim, MD, MS is an associate professor of pediatrics at the University of North Carolina (UNC) School of Medicine and chief of the division of pediatric allergy and immunology. He is director of the UNC Food Allergy Initiative research group, which focuses on multiple aspects of food immunotherapy including safety and tolerability of immunotherapy, varying levels of clinical desensitization, and immune mechanisms involved in successful treatment. Dr. Kim is also interested in research that focuses on the development of novel therapeutics for food allergy. As director, his goal is to recruit and train the next generation of leaders in allergy and immunology through strong clinical training and productive research opportunities.Kristie Herring
Kristie Herring
Caregiver
Ruchi Gupta, MD, MPH
Ruchi Gupta, MD, MPH
Professor of Pediatrics and Medicine
Ruchi Gupta, MD, MPH is a professor of pediatrics and medicine at Northwestern University Feinberg School of Medicine and a clinical attending at the Ann & Robert H. Lurie Children’s Hospital of Chicago. With more than 20 years of experience as a board-certified pediatrician and health researcher, Dr. Gupta is the founding director of the Center for Food Allergy & Asthma Research (CFAAR). She is world-renowned for her groundbreaking research in the areas of food allergy and asthma epidemiology, most notably for her research on the prevalence of pediatric and adult food allergy in the United States. She has also significantly contributed to academic research in the areas of food-allergy prevention, socioeconomic disparities in care, and daily management of these conditions.
Seeking Control for Moderate‐to‐Severe Asthma
Michael Wechsler, MD, MMSc
Michael Wechsler, MD, MMSc
Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine
Michael Wechsler, MD, MMSc, is a Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health (NJH), Director of the NJH/Cohen Family Asthma Institute, and Associate Vice President for Innovation and Industry Relations at NJH. In addition to clinical work in pulmonary & critical care medicine, Dr. Wechsler’s research focuses on clinical and translational asthma with emphasis on clinical trials in asthma, novel asthma therapies, bronchial thermoplasty, asthma pharmacogenomics, and management of eosinophilic granulomatosis with polyangiitis (i.e. Churg-Strauss Syndrome, CSS). He has led studies focusing on novel biologic agents for asthma and related diseases, including benralizumab, dupilumab, mepolizumab, reslizumab, and tezepelumab.Anju Peters, MD, MS
Anju Peters, MD, MS
Professor of Medicine
Anju Peters, MD, MS, is a Professor in the Department of Medicine at Northwestern. Moreover, she is the Director of Clinical Research in the Division of Allergy-Immunology and the Medical Director of the Northwestern Medicine Clinical Research Unit. Furthermore, Dr. Peters is the Director of the Center for Clinical Research at the Northwestern University Clinical and Translational Sciences Institute. Her research focuses on the field of chronic rhinosinusitis and its associated comorbidities including allergic rhinitis, asthma and immunodeficiencies. Dr. Peters has published extensively in these areas and is currently involved in translational research and clinical trials in asthma and chronic rhinosinusitis. Currently, she practices as an allergist in the Division of Allergy-Immunology.
All Speakers
Stacey Denham, MSW, MPH
Stacey Denham, MSW, MPH
Public Health Manager
Stacey Denham, MSW, MPH, is a Public Health Manager at the Asthma and Allergy Foundation of America (AAFA), the nation’s oldest and leading asthma and allergy charity. She holds an MSW and MPH from Tulane University with a concentration in Maternal and Child Health. Stacey has worked in the asthma and allergy field for over 15 years with an emphasis in community health. She has worked both locally in her community of New Orleans and internationally with non-profit organizations. Stacy believes in the power, diversity, and resilience of each community and the leaders that reside in them to bring healthy behavior change to positive health outcomes. Currently, Stacey resides in New Orleans with her family, where they can be found bike riding, trying out new food spots, and going to festivals.Anju Peters, MD, MS
Anju Peters, MD, MS
Professor of Medicine
Anju Peters, MD, MS, is a Professor in the Department of Medicine at Northwestern. Moreover, she is the Director of Clinical Research in the Division of Allergy-Immunology and the Medical Director of the Northwestern Medicine Clinical Research Unit. Furthermore, Dr. Peters is the Director of the Center for Clinical Research at the Northwestern University Clinical and Translational Sciences Institute. Her research focuses on the field of chronic rhinosinusitis and its associated comorbidities including allergic rhinitis, asthma and immunodeficiencies. Dr. Peters has published extensively in these areas and is currently involved in translational research and clinical trials in asthma and chronic rhinosinusitis. Currently, she practices as an allergist in the Division of Allergy-Immunology.Theresa Guilbert, MD, MS
Theresa Guilbert, MD, MS
Professor
Theresa Guilbert, MD, MS, is a Professor at the University of Cincinnati and the Director of the Asthma Center at Cincinnati Children’s Hospital & Medical Center. Dr. Guilbert’s clinical research focuses on identifying the roles of risk factors, exposures, and environment interactions that lead to early childhood wheezing and severe asthma as well as treatment and intervention strategies to manage asthma. Her clinical research has utilized stakeholder input to develop, implement, and test technology-based interventions for children with asthma, and she has developed a telehealth clinic which serves several urban core school-based health centers. Dr. Guilbert is currently the site PI for several multi-center asthma pediatric trials.Kathleen Buchheit, MD
Kathleen Buchheit, MD
Assistant Professor of Medicine
Katie Buchheit, MD, is the assistant director of the AERD Center at the Brigham and Women’s Hospital (BWH) in Boston, Massachusetts. Her research focuses on understanding aspirin-exacerbated respiratory disease (AERD) and nasal polyposis. She is dedicated to investigating the causative mechanisms and exploring new treatments for these diseases. Dr. Buchheit is principal investigator of an NIH-funded study investigating the role of B cells and plasma cells in the pathogenesis of AERD and nasal polyps, as well as the mechanistic factors associated with nasal polyp recurrence. Clinically, she primarily focuses on the treatment of patients with chronic rhinosinusitis and AERD. During her allergy/immunology fellowship at BWH, she focused on the pathogenesis of nasal polyposis and AERD.Stella Lee, MD
Stella Lee, MD
Director of the Brigham Sinus Center
Stella Lee, MD is a fellowship-trained rhinologist and chief of rhinology at Brigham and Women’s Hospital (BWH)/Harvard Medical School in Boston, Massachusetts. She is a clinician scientist developing novel management strategies for the care of patients with inflammatory upper airway disease and is a leader in developing therapeutics for airway inflammation. Before joining BWH, Dr. Lee was the division chief for sino-nasal disorders and allergy in the Department of Otolaryngology at the University of Pittsburgh Medical Center for ten years. Her research interests include defining inflammatory endotypes of chronic rhinosinusitis, the impact of environmental pollution on airway inflammation, and the development of basic to translational approaches to solve chronic inflammation.Noam Cohen, MD, PhD
Noam Cohen, MD, PhD
Professor of Otorhinolaryngology – Head and Neck Surgery, Director of Rhinology Research
Noam Cohen, MD, PhD is the Ralph Butler endowed professor of otorhinolaryngology – head and neck surgery and director of rhinology research at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. He is an adjunct member of the Monell Chemical Senses Center and a staff surgeon at the Philadelphia VA Medical Center. His research interests include host-microbe interactions in the upper airway, focusing on sinonasal innate defenses (airway taste receptors and mucociliary clearance), microbial biofilms, solitary chemosensory cells, and development of novel sinonasal topical antimicrobial therapies. He has authored more than 200 publications, given multiple presentations around the world, and has been principal investigator on NIH and VA grants, as well as industry-sponsored studies.Raymond Cross, M.D., M.S., A.G.A.F., F.A.C.G
Raymond Cross, M.D., M.S., A.G.A.F., F.A.C.G
Professor of Medicine, Division of Gastroenterology and Hepatology
Raymond Cross, M.D., M.S., A.G.A.F., F.A.C.G. is a Professor of Medicine, Division of Gastroenterology and Hepatology, at the University of Maryland, Baltimore. Also, he is Director of the Inflammatory Bowel Disease Program at the University of Maryland School of Medicine and Director of the Digestive Health Center at the University of Maryland Medical Center. Dr. Cross has authored over 170 journal articles, reviews, and book chapters. His research interests include application of telemedicine in the care of patients with IBD, disparities, outcomes research and clinical trials. Furthermore, Dr. Cross is Co-Chair of the Clinical Research Alliance, Research & Investigator Engagement Lead for SPARC IBD, and Scientific Co-Director of the Corevitas Registry.Florence-Damilola Odufalu, MD
Florence-Damilola Odufalu, MD
Assistant Professor of Clinical Medicine
Florence-Damilola Odufalu, MD is a passionate provider and clinical researcher in gastroenterology and inflammatory bowel diseases (IBD), including Crohn’s disease, ulcerative colitis, indeterminate colitis, and microscopic colitis. Her research and clinical interests include disparities research, women’s health, and pregnancy as each relates to IBD. Dr. Odufalu has published many ground-breaking research articles and reviews assessing IBD care in pregnancy and in ethnic minority groups and serves on the editorial board of Inflammatory Bowel Diseases Journal.Robert Wood, MD
Robert Wood, MD
Professor of Pediatrics
Dr. Robert Wood is Professor of Pediatrics, Chief of Pediatric Allergy, Immunology, and Rheumatology, Director of the Pediatric Clinical Research Unit, and Deputy Director of the Institute of Clinical and Translational Research at the Johns Hopkins University School of Medicine. He is recognized internationally as an expert in both food allergy and childhood asthma and has published over 300 manuscripts and book chapters, as well as four books. He has served on numerous editorial boards and other leadership positions, including President of the American Academy of Allergy, Asthma, and Immunology.Edwin Kim, MD, MS
Edwin Kim, MD, MS
Associate Professor of Pediatrics
Edwin Kim, MD, MS is an associate professor of pediatrics at the University of North Carolina (UNC) School of Medicine and chief of the division of pediatric allergy and immunology. He is director of the UNC Food Allergy Initiative research group, which focuses on multiple aspects of food immunotherapy including safety and tolerability of immunotherapy, varying levels of clinical desensitization, and immune mechanisms involved in successful treatment. Dr. Kim is also interested in research that focuses on the development of novel therapeutics for food allergy. As director, his goal is to recruit and train the next generation of leaders in allergy and immunology through strong clinical training and productive research opportunities.Jennifer Dantzer, MD, MHS
Jennifer Dantzer, MD, MHS
Assistant Professor of Pediatrics, Division of Allergy
Jennifer Dantzer, MD, MHS is a pediatric allergist and immunologist with a focus on food allergy treatments and patient-centered outcomes. She is an assistant professor of pediatrics at the Johns Hopkins School of Medicine in the division of allergy, immunology, and rheumatology. In 2021, Dr. Dantzer was awarded the Johns Hopkins Clinical Scholar Award and NIH/NIAID K23 award to study patient-centered outcomes of the first FDA-approved food allergy treatment. She is a co-investigator in the Consortium for Food Allergy Research and participates in numerous food allergy research projects. She has published numerous articles in leading allergy and immunology journals, including five review articles on novel treatments for food allergy, and has presented at several national conferences.Luann Curry
Luann Curry
Interview Participant - Patient with HAE
Marc Riedl, MD, MS
Marc Riedl, MD, MS
Professor of Medicine
Marc Riedl, MD, MS is a professor of medicine and clinical director of the United States Hereditary Angioedema Association (US HAEA) Angioedema Center at the University of California, San Diego (UCSD), where he also serves as clinical service chief for allergy and immunology. He directs an active clinical research program focused on angioedema and immunodeficiency conditions and lectures frequently at national and international medical conferences. He has published more than 140 peer-reviewed manuscripts and serves on numerous scientific committees, as well as appointed expert panels for the US Food and Drug Administration (FDA) and National Institutes of Health (NIH). He serves on the US HAEA Medical Advisory Board, the Immune Deficiency Foundation Physician Advisory Committee, and the Board of Directors for the Western Society of Allergy, Asthma, and Immunology.Timothy Craig, DO, FAAAAI, FACAAI, FACP, FACOI
Timothy Craig, DO, FAAAAI, FACAAI, FACP, FACOI
Tenured Professor of Medicine
Timothy Craig, DO, FAAAAI, FACAAI, FACP, FACOI is a tenured professor of medicine, pediatrics, and biomedical sciences and is a distinguished educator at Pennsylvania State University (PSU). He is director of the Allergy, Immunology, and Respiratory Clinical Research, as well as the PSU Alpha-1 Foundation Clinical Resource Center and the International Angioedema Resource Center (ACARE). He has served as a leader in multiple organizations, including the Asthma Diagnosis and Treatment Interest Section Chair for the American Academy of Allergy, Asthma & Immunology (AAAAI). He also serves on the Medical Advisory Board for the US Hereditary Angioedema Association. A successful clinical researcher and mentor, Dr. Craig has published more than 350 manuscripts, delivered more than 500 invited lectures and 450 abstracts, and has served on numerous editorial boards.Mirna Chehade, MD, MPH, AGAF, FAAAAI
Mirna Chehade, MD, MPH, AGAF, FAAAAI
Professor of Pediatrics and Medicine
Mirna Chehade, MD, MPH is a professor of pediatrics and medicine at the Icahn School of Medicine at Mount Sinai in New York City. She is a board-certified pediatric gastroenterologist and the founding director of the Mount Sinai Center for Eosinophilic Disorders (MSCED). The center provides cutting-edge clinical care, research, and support for patients with eosinophilic gastrointestinal diseases (EGIDs) including eosinophilic esophagitis (EoE). She is an active member in national and international organizations, and has several publications on EGIDs, including the efficacy and safety of various therapies for EGIDs, potential reasons EGIDs are missed, and long-term outcomes of EGIDs. She is a frequently invited speaker at national and international meetings, and an invited reviewer for several highly ranked gastroenterology and allergy journals.Kathryn Peterson, MD, MSci
Kathryn Peterson, MD, MSci
Professor of Medicine
Kathy Peterson, MD is a professor of medicine at the University of Utah in Salt Lake City. She also co-directs the multidisciplinary clinic for gastrointestinal eosinophilic disorders. Her specialties lie in the diagnosis and treatment of diseases of the digestive system, including eosinophilic esophagitis, Barrett’s esophagus, and inflammatory bowel disease. Her research focuses on novel methods to diagnose, risk stratify, and treat eosinophilic esophagitis and other eosinophilic gastrointestinal diseases (EGIDs). She completed her medical degree at the University of Texas Southwestern in Dallas, followed by a residency and fellowship at the University of Utah and a master’s program in epidemiology at Harvard University in Boston, MA.Angela Lamb, MD
Angela Lamb, MD
Associate Professor, Vice Chair of Clinical Operations
Angela Lamb, MD is a New York City dermatologist who treats patients of all ages for acne, atopic dermatitis, skin-cancer detection, and numerous other skin disorders, including many for patients undergoing cancer treatment. Serving in several leadership roles at Mount Sinai, Dr. Lamb is director of the Westside Mount Sinai Dermatology Faculty Practice and an associate professor of dermatology. She was recently promoted to System Vice Chair of Dermatology Clinical Operations and Strategy and also serves as medical director of the Mount Sinai Doctors Patient Access Center. Dr. Lamb is intent on partnering with her patients to determine the best course of treatment and ongoing care.Anne Marie Singh, MD
Anne Marie Singh, MD
Associate Professor, Interim Division Head, Division of Allergy, Immunology and Rheumatology
Anne Marie Singh, MD is an associate professor of pediatrics; interim division chief of the Division of Allergy, Immunology and Rheumatology; and director of the Food Allergy Research and Education Clinical Research Center of Distinction at the University of Wisconsin School of Medicine and Public Health. She also has affiliate appointments in the Departments of Dermatology, Medical Microbiology and Immunology, and Food Research. Dr. Singh’s research is focused on advancing the clinical care of patients with early atopic diseases, including atopic dermatitis and food allergy, as well as mechanistic studies on the effects of environmental and microbial exposures on development of allergic diseases. She is leading the Childhood Allergy and NeOnatal Environment (CANOE) birth cohort as part of NIH’s Environmental Childhood Health Outcomes (ECHO) study.Eugenio De Corso, MD, PhD
Eugenio De Corso, MD, PhD
Ear, Nose, and Throat Specialist
Eugenio De Corso, MD, PhD is an ear, nose, and throat specialist at the Institute of Otorhinolaryngology, A. Gemelli University Hospital Foundation, Catholic University of the Sacred Heart in Rome, Italy. His principal areas of clinical expertise are nasal polyps, chronic rhinosinusitis, allergic and nonallergic rhinitis, sinusitis, and otitis media. His research interests include endoscopic treatment, laryngectomy, brachytherapy, otosclerosis surgery, type 2 inflammation in nonallergic rhinitis, and the management of patients with chronic rhinosinusitis with nasal polyps (CRSwNP). He has overseen clinical studies of patients undergoing new therapies, such as biologics for severe uncontrolled CRSwNP and the efficacy of biologics on refractory eosinophilic otitis media associated with CRSwNP. He has authored or co-authored more than 100 publications and has reviewed several international journals.Marco Caminati, MD
Marco Caminati, MD
Allergy and Clinical Immunology Specialist
Marco Caminati, MD is an allergy and clinical immunology specialist, as well as an assistant professor in allergy, clinical immunology, and severe asthma at the University of Verona Asthma Center and Allergy Unit at Verona University Hospital in Verona, Italy. Most of his clinical and scientific activity focuses on asthma, severe asthma, and associated comorbidities, including chronic rhinosinusitis with nasal polyps (CRSwNP), as well as biologics and immunotherapy. His research interests include rare autoimmune disorders with hypereosinophilic syndrome (HES), eosinophilic granulomatosis with polyangiitis (EGPA), and eosinophilic esophagitis (EoE), with a special focus on new targeted therapies. He co-chaired the Junior Members Steering Group of the World Allergy Organization (WAO) and was involved in the European Academy of Allergy and Clinical Immunology (EAACI) Junior Member Assembly.Zachariah DeFilipp, MD
Zachariah DeFilipp, MD
Director of BMT Clinical Research
Zachariah DeFilipp, MD, is an attending physician in the Hematopoietic Cell Transplant and Cell Therapy Program at the Massachusetts General Hospital Cancer Center. He serves as Director of BMT Clinical Research and an Assistant Professor in Medicine at Harvard Medical School. Dr. DeFilipp is involved in translational and clinical research initiatives to improve outcomes for patients undergoing allogeneic hematopoietic cell transplantation. His research is on the development of approaches to the prevention and treatment of graft-versus-host disease. Also, his research efforts have explored improving transplant outcomes for high-risk leukemia through the incorporation of targeted agents in pre- and post-transplant and examining late effects following amongst long-term transplant survivors.Andrew Rogers
Andrew Rogers
Assistant Professor of Medicine
Andrew Rogers, MD is a hematologist at MaineHealth Cancer Care in South Portland, Maine. He serves as assistant program director for the Hematology/Medical Oncology Fellowship program at Maine Medical Center. He completed his fellowship training in hematology and medical oncology at The Ohio State University in Columbus, Ohio. His clinical interests include blood cancers such as leukemia, lymphoma, and myeloma.Kristie Herring
Kristie Herring
Caregiver
Ruchi Gupta, MD, MPH
Ruchi Gupta, MD, MPH
Professor of Pediatrics and Medicine
Ruchi Gupta, MD, MPH is a professor of pediatrics and medicine at Northwestern University Feinberg School of Medicine and a clinical attending at the Ann & Robert H. Lurie Children’s Hospital of Chicago. With more than 20 years of experience as a board-certified pediatrician and health researcher, Dr. Gupta is the founding director of the Center for Food Allergy & Asthma Research (CFAAR). She is world-renowned for her groundbreaking research in the areas of food allergy and asthma epidemiology, most notably for her research on the prevalence of pediatric and adult food allergy in the United States. She has also significantly contributed to academic research in the areas of food-allergy prevention, socioeconomic disparities in care, and daily management of these conditions.Michael Wechsler, MD, MMSc
Michael Wechsler, MD, MMSc
Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine
Michael Wechsler, MD, MMSc, is a Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health (NJH), Director of the NJH/Cohen Family Asthma Institute, and Associate Vice President for Innovation and Industry Relations at NJH. In addition to clinical work in pulmonary & critical care medicine, Dr. Wechsler’s research focuses on clinical and translational asthma with emphasis on clinical trials in asthma, novel asthma therapies, bronchial thermoplasty, asthma pharmacogenomics, and management of eosinophilic granulomatosis with polyangiitis (i.e. Churg-Strauss Syndrome, CSS). He has led studies focusing on novel biologic agents for asthma and related diseases, including benralizumab, dupilumab, mepolizumab, reslizumab, and tezepelumab.